CCO Annual Report (2022)

We are glad to present a brief introduction of CCO’s progress in 2022 here. CCO grew steadily and published 51 papers last year, including 32 Review Articles and 4 Original Articles in total. According to the Google Analytics, CCO journal website had an increasing number of pageviews (all together 204,057 visitors worldwide and 345,615 pageviews in 2022). Two special series have been published, and four special series are ongoing.

Read More>>

Welcome to join us at the 18^th St. Gallen International Breast Cancer Conference 2023, Vienna, Austria, 15 - 18 March!

The 18^th St. Gallen International Breast Cancer Conference 2023 will be held in Vienna, Austria this year during 15-18 March. More details can be seen: https://www.oncoconferences.ch/events/sg-bcc-2023/.

This time, Chinese Clinical Oncology (CCO) as well as its sister journals and books published by AME Publishing Company will be on display during this exciting academic event! We will also seize this great opportunity to meet our authors, editorial board members and readers.

Read More>>

Progress and Future Direction to Treat Advanced Gastric Cancer (Ongoing)

This series on “Progress and Future Direction to Treat Advanced Gastric Cancer” is edited by Prof. Yasuhide Yamada from Comprehensive Cancer Center, National Center for Global Health and Medicine, Japan.

Read More>>

Inflammatory Breast Cancer

This series on "Inflammatory Breast Cancer" is edited by Professor Naoto T. Ueno from Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, USA.

Read More>>

Chinese Clinical Oncology is going to receive its first impact factor in June 2023

According to the latest news of Web of Science, Clarivate Analytics on July 26, 2022, in the 2023 release of the Journal Citation Report™, all Web of Science Core Collection™ journals will receive a Journal Impact Factor (JIF)™. This means expanding the JIF from Science Citation Index Expanded (SCIE)™ and Social Science Citation Index (SSCI)™ to include journals from the Arts and Humanities Citation Index (AHCI)™ and the multidisciplinary Emerging Sources Citation Index (ESCI)™.

Read More>>

Interview with Prof. Rimas V. Lukas: discussion with an academic neuro-oncologist

Photo of Prof. Rimas V. Lukas.

Read More>>

Interviews with Outstanding Authors (2022)

In 2022, many authors make outstanding contributions to our journal. Their articles published with us have received very well feedback in the field and stimulate a lot of discussions and new insights among the peers.

Hereby, we would like to highlight some of our outstanding authors who have been making immense efforts in their research fields, with a brief interview of their unique perspectives and insightful views as authors.

Read More>>

Unresolved Issues in Pancreatic Cancer

This series on "Unresolved Issues in Pancreatic Cancer" is edited by Professor Savio George Barreto from Hepatobiliary & Oesophagogastric Unit, Division of Surgery & Perioperative Medicine, Flinders Medical Centre, Bedford Park, Adelaide, South Australia, Australia; College of Medicine & Public Health, Flinders University, South Australia, Australia.

Read More>>

Hepatobiliary and Pancreatic Cancers: an update of surgical treatments (Ongoing)

This series on "Hepatobiliary and Pancreatic Cancers: an update of surgical treatments" is edited by Professor Giovanni Battista Levi Sandri from Department of General Surgery and Transplantation, San Camillo Forlanini Hospital, Rome, Italy.

Read More>>